1
|
Georgopoulou AN, Giannakou A, Vassilakopoulos TP, Siakantaris M, Georgopoulos NA, Kalantaridou S, Lalou E, Keramaris K, Loukari E, Arapaki M, Konstantinou I, Machairas A, Kopsaftopoulou A, Mammali I, Vassilopoulos I, Galopoulos D, Angelopoulou MK. P1085: EVALUATION OF GONADAL FUNCTION IN YOUNG WOMEN DIAGNOSED WITH HODGKIN AND NON-HODGKIN LYMPHOMA. Hemasphere 2022. [PMCID: PMC9429613 DOI: 10.1097/01.hs9.0000847208.88336.02] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
|
2
|
Velissari A, Vassilakopoulos TP, Angelopoulou MK, Korkolopoulou P, Bamias G, Daikos G, Konstantopoulos K, Siakantaris M. Genetic polymorphisms and risk of MALT lymphoma in Greek population. Curr Res Transl Med 2021; 70:103330. [PMID: 34979486 DOI: 10.1016/j.retram.2021.103330] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/01/2021] [Revised: 11/22/2021] [Accepted: 12/20/2021] [Indexed: 11/03/2022]
Abstract
PURPOSE MALT lymphoma is thought to have a genetic component. Genetic studies in the greek population are rare and genetic determinants remain to be established. The current study aimed to seek correlations between genetic polymorphisms and risk of MALT lymphoma in the Greek population. PATIENTS AND METHODS 83 MALT lymphoma patients and 60 age-matched healthy outpatients were recruited. SNPs in TNFa, LTA and CTLA-4 genes and IL1RN-VNTR and GSTT1 and GSTTM1 null polymorphisms were genotyped using published PCR/PCR-RFLP methods, while two novel PCR-RFLP methods were developed for IL-22 rs7314777 and TCF19 rs7750641 SNPs. Part of the results was validated by DNA-sequencing. Statistical analysis was performed using SPSS and the SNPstats bioinformatic tool. RESULTS The mean age of the patients and controls were 55.9 and 56.2 years respectively. The majority of patients (63) suffered gastric marzinal zone lymphoma (GMZL) and 71.1% were stage I at diagnosis. A statistically significant association was noted for the CTLA-4 49A/ G G variant (OR:2.56,p: 0.006) and the TCF19 rs7750641 SNP T variant (OR: 3.86, p:0.023). CONCLUSIONS Our study confirmed a role for CTLA-4 49A/G and TCF19 rs7750641 SNPs in the Greek population. Additional studies could help confirm these associations and possibly link them to prognosis or response to treatment parameters.
Collapse
Affiliation(s)
- A Velissari
- Hematology Department, National and Kapodistrian University of Athens, Laiko General Hospital.
| | - T P Vassilakopoulos
- Hematology Department, National and Kapodistrian University of Athens, Laiko General Hospital
| | - M K Angelopoulou
- Hematology Department, National and Kapodistrian University of Athens, Laiko General Hospital
| | - P Korkolopoulou
- First Department of Pathology, Medical School, National and Kapodistrian University of Athens
| | - G Bamias
- Gastrenterology Department, National and Kapodistrian University of Athens, Laiko General Hospital
| | - G Daikos
- First Department of Internal Medicine, National and Kapodistrian University of Athens, Laiko General Hospital
| | - K Konstantopoulos
- Hematology Department, National and Kapodistrian University of Athens, Laiko General Hospital
| | - M Siakantaris
- Hematology Department, National and Kapodistrian University of Athens, Laiko General Hospital
| |
Collapse
|
3
|
Velissari A, Lakiotaki E, Nikolaou V, Argyropoulos KV, Stratigos A, Daikos G, Konstantopoulos K, Siakantaris M. Genetic polymorphisms in immunity related genes and the vitamin D receptor gene and risk of cutaneous T-cell lymphoma in Greek population. J Eur Acad Dermatol Venereol 2021; 35:e805-e807. [PMID: 34173274 DOI: 10.1111/jdv.17482] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/15/2021] [Revised: 05/23/2021] [Accepted: 06/10/2021] [Indexed: 11/29/2022]
Affiliation(s)
- A Velissari
- Hematology Department, Laiko General Hospital, National and Kapodistrian University of Athens, Athens, Greece
| | - E Lakiotaki
- First Department of Pathology, Medical School, National and Kapodistrian University of Athens, Athens, Greece
| | - V Nikolaou
- 1st Department of Dermatology, A. Syggros Hospital for Skin Diseases, Athens, Greece
| | - K V Argyropoulos
- Department of Pathology, School of Medicine, New York University, New York, NY, USA
| | - A Stratigos
- 1st Department of Dermatology, A. Syggros Hospital for Skin Diseases, Athens, Greece
| | - G Daikos
- First Department of Internal Medicine, National and Kapodistrian University of Athens, Laiko General Hospital, Athens, Greece
| | - K Konstantopoulos
- Hematology Department, Laiko General Hospital, National and Kapodistrian University of Athens, Athens, Greece
| | - M Siakantaris
- Hematology Department, Laiko General Hospital, National and Kapodistrian University of Athens, Athens, Greece
| |
Collapse
|
4
|
Vassilakopoulos T, Ferhanoglu B, Horowitz N, Mellios Z, Kaynar L, Zektser M, Symeonidis A, Piperidou A, Kalpadakis C, Akay OM, Atalar AC, Katodritou E, Leonidopoulou T, Papageorgiou S, Tadmor T, Gutwein O, Karakatsanis S, Ganzel C, Karianakis G, Isenberg G, Gainaru G, Vrakidou E, Palassopoulou M, Ozgur M, Siakantaris M, Paydas S, Tsirigotis P, Tsirogianni M, Hatzimichael E, Tuglular T, Chatzidimitriou C, Megalakaki E, Kanellias N, Zikos P, Koumarianou A, Gafter‐Gvili A, Angelopoulou M, Karmiris T, Gurion R. RITUXIMAB‐DOSE‐ADJUSTED EPOCH (R‐DA‐EPOCH) IN PRIMARY MEDIASTINAL LARGE B‐CELL LYMPHOMA (PMLBCL): REAL‐LIFE EXPERIENCE ON 190 PATIENTS FROM 3 MEDITERRANEAN COUNTRIES. Hematol Oncol 2021. [DOI: 10.1002/hon.76_2880] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
|
5
|
Argyropoulos KV, Pulitzer M, Perez S, Korkolopoulou P, Angelopoulou M, Baxevanis C, Palomba ML, Siakantaris M. Tumor-infiltrating and circulating granulocytic myeloid-derived suppressor cells correlate with disease activity and adverse clinical outcomes in mycosis fungoides. Clin Transl Oncol 2019; 22:1059-1066. [PMID: 31696413 DOI: 10.1007/s12094-019-02231-7] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/05/2019] [Accepted: 10/17/2019] [Indexed: 12/31/2022]
Abstract
PURPOSE Cutaneous T cell lymphomas (CTCL) are rare and histologically diverse lymphoproliferative neoplasms, with mycosis fungoides (MF) representing the most common disease subset. Given the emerging role of myeloid-derived suppressor cells (MDSC) as a clinically applicable biomarker in solid tumors, we sought to investigate the presence of tumor-infiltrating and circulating MDSC in early- and advanced-stage MF patients and evaluate their prognostic significance in patient overall survival. METHODS Tumor-infiltrating MDSC were assessed immunohistochemically with Arginase-1 in 31 MF and 14 non-MF skin punch biopsies. Circulating MDSC were assessed with flow cytometry in freshly isolated PBMC from 29 MF patients. Granulocytic MDSC (G-MDSC) were defined as CD11b+CD14-CD15+ and monocytic MDSC (M-MDSC) were defined as CD11b+CD14+HLA-DRlow/-. RESULTS MDSC infiltration occurred in approximately one-third (35.5%) of CTCL lesions, with a predilection for non-MF lesions (p < 0.05). The predominant morphology of MDSC was granulocytic. Although in MF lesions the presence of MDSC infiltrates did not correlate with clinical stage, it conferred significantly worse overall survival outcomes (p < 0.05). Circulating G-MDSC were significantly higher in MF patients compared to healthy donor controls (p < 0.0001), while M-MDSC did not show any statistically significant difference. G-MDSC were significantly higher in patients with active disease compared to patients who were in partial remission (p < 0.01). As with tumor-infiltrating MDSC, clinical stage did not correlate with circulating G-MDSC levels, while prospective overall survival analysis showed that patients with high levels of circulating G-MDSC have significantly inferior outcomes (p < 0.01). CONCLUSIONS This study shows that G-MDSC could represent a novel and easily assessable biomarker in MF, which mirrors disease activity and can predict patient subgroups with aggressive clinical features.
Collapse
Affiliation(s)
- K V Argyropoulos
- Immunology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
- Hematology Department, Laiko General Hospital, National and Kapodistrian University of Athens, Athens, Greece.
| | - M Pulitzer
- Pathology Department, Memorial Sloan Kettering Cancer Center, New York, USA
| | - S Perez
- Cancer Immunology and Immunotherapy Center, Saint Savas Cancer Hospital, Athens, Greece
| | - P Korkolopoulou
- Pathology Department, National and Kapodistrian University of Athens, Athens, Greece
| | - M Angelopoulou
- Hematology Department, Laiko General Hospital, National and Kapodistrian University of Athens, Athens, Greece
| | - C Baxevanis
- Cancer Immunology and Immunotherapy Center, Saint Savas Cancer Hospital, Athens, Greece
| | - M L Palomba
- Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, USA
| | - M Siakantaris
- Hematology Department, Laiko General Hospital, National and Kapodistrian University of Athens, Athens, Greece
| |
Collapse
|
6
|
Kalpadakis C, Pangalis G, Konstantinou E, Vassilakopoulos T, Telonis V, Sachanas S, Tsirkinidis P, Moschogiannis M, Yiakoumis X, Siakantaris M, Tsaftaridis P, Iliakis T, Befani M, Kyrtsonis M, Dimitrakopoulou A, Boutsikas G, Korkolopoulou P, Kontopidou F, Koulieris E, Pontikoglou C, Ximeri M, Psylaki M, Roumelioti M, Rontogiannis D, Papadaki H, Panagiotidis P, Angelopoulou M. CLONAL B-CELL LYMPHOCYTOSIS OF MARGINAL ZONE ORIGIN (CBL-MZ): DESCRIPTION OF MAIN CLINICAL FEATURES, DISEASE EVOLUTION AND OUTCOME IN A SERIES OF 100 PATIENTS. Hematol Oncol 2019. [DOI: 10.1002/hon.38_2630] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Affiliation(s)
- C. Kalpadakis
- Department of Haematology; University Hospital, University of Crete; Heraklion Crete Greece
| | - G.A. Pangalis
- Department of Haematology; Athens Medical Center; Athens Greece
| | - E. Konstantinou
- Department of Haematology; University of Athens, Laikon General Hospital; Athens Greece
| | - T.P. Vassilakopoulos
- Department of Haematology; University of Athens, Laikon General Hospital; Athens Greece
| | - V. Telonis
- Department of Haematology; University of Athens, Laikon General Hospital; Athens Greece
| | - S. Sachanas
- Department of Haematology; Athens Medical Center; Athens Greece
| | - P. Tsirkinidis
- Department of Haematology; Athens Medical Center; Athens Greece
| | | | - X. Yiakoumis
- Department of Haematology; Athens Medical Center; Athens Greece
| | - M. Siakantaris
- Department of Haematology; University of Athens, Laikon General Hospital; Athens Greece
| | - P. Tsaftaridis
- Department of Haematology; University of Athens, Laikon General Hospital; Athens Greece
| | - T. Iliakis
- Department of Haematology; University of Athens, Laikon General Hospital; Athens Greece
| | - M. Befani
- Department of Haematology; University of Athens, Laikon General Hospital; Athens Greece
| | - M. Kyrtsonis
- 1st Department of Propedeutics; University of Athens, Laikon General Hospital; Athens Greece
| | - A. Dimitrakopoulou
- Immunology Laboratory; University of Athens, Laikon General Hospital; Athens Greece
| | - G. Boutsikas
- Department of Haematology; University of Athens, Laikon General Hospital; Athens Greece
| | - P. Korkolopoulou
- Department of Pathology; University of Athens, Laikon General Hospital; Athens Greece
| | - F. Kontopidou
- Second Department of Internal Medicine; Hippokrateio General Hospital, University of Athens; Athens Greece
| | - E. Koulieris
- Department of Haematology; Athens Medical Center; Athens Greece
| | - C. Pontikoglou
- Department of Haematology; University Hospital, University of Crete; Heraklion Crete Greece
| | - M. Ximeri
- Department of Haematology; University Hospital, University of Crete; Heraklion Crete Greece
| | - M. Psylaki
- Department of Haematology; University Hospital, University of Crete; Heraklion Crete Greece
| | - M. Roumelioti
- 1st Department of Propedeutics; University of Athens, Laikon General Hospital; Athens Greece
| | - D. Rontogiannis
- Department of Anatomic Pathology; Evangelismos General Hospital; Athens Greece
| | - H. Papadaki
- Department of Haematology; University Hospital, University of Crete; Heraklion Crete Greece
| | - P. Panagiotidis
- 1st Department of Propedeutics; University of Athens, Laikon General Hospital; Athens Greece
| | - M.K. Angelopoulou
- Department of Haematology; University of Athens, Laikon General Hospital; Athens Greece
| |
Collapse
|
7
|
Nikolaou V, Papadavid E, Patsatsi A, Siakantaris M, Economidi A, Marinos L, Koletsa T, Georgiou E, Pappa V, Stratigos A, Antoniou C. Prognostic indicators for mycosis fungoides in a Greek population. Br J Dermatol 2017; 176:1321-1330. [DOI: 10.1111/bjd.15000] [Citation(s) in RCA: 17] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 08/20/2016] [Indexed: 12/12/2022]
Affiliation(s)
- V. Nikolaou
- National and Kapodistrian University of Athens; Medical School; Athens Greece
| | - E. Papadavid
- National and Kapodistrian University of Athens; Medical School; Athens Greece
| | - A. Patsatsi
- Aristotle University School of Medicine; Thessaloniki Greece
| | - M. Siakantaris
- National and Kapodistrian University of Athens; Medical School; Athens Greece
| | - A. Economidi
- National and Kapodistrian University of Athens; Medical School; Athens Greece
| | - L. Marinos
- Department of Hemopathology; Evangelismos Hospital; Athens Greece
| | - T. Koletsa
- Aristotle University School of Medicine; Thessaloniki Greece
| | - E. Georgiou
- Aristotle University School of Medicine; Thessaloniki Greece
| | - V. Pappa
- National and Kapodistrian University of Athens; Medical School; Athens Greece
| | - A. Stratigos
- National and Kapodistrian University of Athens; Medical School; Athens Greece
| | - C. Antoniou
- National and Kapodistrian University of Athens; Medical School; Athens Greece
| |
Collapse
|
8
|
Antoniou C, Nikoloau V, Siakantaris M, Bamia C, Stratigos A, Stavrianeas N, Katsambas A, Papadavid E. A chart review of patients with early-stage mycosis fungoides treated with psoralen plus ultraviolet A. J Eur Acad Dermatol Venereol 2009; 23:218-9. [DOI: 10.1111/j.1468-3083.2008.02800.x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|